1. Home
  2. LUCD vs PTAC Comparison

LUCD vs PTAC Comparison

Compare LUCD & PTAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lucid Diagnostics Inc.

LUCD

Lucid Diagnostics Inc.

N/A

Current Price

$0.90

Market Cap

192.9M

Sector

Health Care

ML Signal

N/A

PTAC

Patriot Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$9.94

Market Cap

219.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
LUCD
PTAC
Founded
2018
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
192.9M
219.5M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
LUCD
PTAC
Price
$0.90
$9.94
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$4.13
N/A
AVG Volume (30 Days)
764.8K
57.4K
Earning Date
05-13-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
16.67
N/A
EPS
N/A
N/A
Revenue
$4,346,000.00
N/A
Revenue This Year
$115.58
N/A
Revenue Next Year
$130.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
79.00
N/A
52 Week Low
$0.86
$9.88
52 Week High
$1.63
$9.99

Technical Indicators

Market Signals
Indicator
LUCD
PTAC
Relative Strength Index (RSI) 38.18 42.58
Support Level $0.88 $9.88
Resistance Level $1.07 N/A
Average True Range (ATR) 0.05 0.01
MACD -0.01 0.00
Stochastic Oscillator 6.12 16.67

Price Performance

Historical Comparison
LUCD
PTAC

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

About PTAC Patriot Acquisition Corp. Class A Ordinary Shares

Patriot Acquisition Corp is a blank check company.

Share on Social Networks: